These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 199270)

  • 21. Cloning and expression in Escherichia coli of the perfringolysin O (theta-toxin) gene from Clostridium perfringens and characterization of the gene product.
    Tweten RK
    Infect Immun; 1988 Dec; 56(12):3228-34. PubMed ID: 2903127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Production, purification and characterization of some Clostridium perfringens toxins].
    Capunzo M; Mariano A; Cavallo R
    G Batteriol Virol Immunol; 1982; 75(1-6):48-61. PubMed ID: 6315516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and characterization of salmolysin, an extracellular hemolytic toxin from Aeromonas salmonicida.
    Nomura S; Fujino M; Yamakawa M; Kawahara E
    J Bacteriol; 1988 Aug; 170(8):3694-702. PubMed ID: 3136147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification and characterization of Clostridium difficile toxin.
    Rolfe RD; Finegold SM
    Infect Immun; 1979 Jul; 25(1):191-201. PubMed ID: 478634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production and properties of theta-toxin of Clostridium perfringens with special reference to lethal activity.
    Soda S; Ito A; Yamamoto A
    Jpn J Med Sci Biol; 1976 Dec; 29(6):335-49. PubMed ID: 192930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile.
    Banno Y; Kobayashi T; Kono H; Watanabe K; Ueno K; Nozawa Y
    Rev Infect Dis; 1984; 6 Suppl 1():S11-20. PubMed ID: 6426016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production, purification, and characterization of botulinolysin, a thiol-activated hemolysin of Clostridium botulinum.
    Haque A; Sugimoto N; Horiguchi Y; Okabe T; Miyata T; Iwanaga S; Matsuda M
    Infect Immun; 1992 Jan; 60(1):71-8. PubMed ID: 1729198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and characterization of Clostridium perfringens iota toxin: dependence on two nonlinked proteins for biological activity.
    Stiles BG; Wilkins TD
    Infect Immun; 1986 Dec; 54(3):683-8. PubMed ID: 2877949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and purification of functional Clostridium perfringens alpha and epsilon toxins in Escherichia coli.
    Zhao Y; Kang L; Gao S; Zhou Y; Su L; Xin W; Su Y; Wang J
    Protein Expr Purif; 2011 Jun; 77(2):207-13. PubMed ID: 21300155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium perfringens exotoxins. II. Purification and some properties of theta-toxin.
    Mitsui K; Mitsui N; Hase J
    Jpn J Exp Med; 1973 Oct; 43(5):377-91. PubMed ID: 4359556
    [No Abstract]   [Full Text] [Related]  

  • 31. [Purification and characterization of "Clostridium perfringens" BP6K-N5 strain bacteriocin N5 (author's transl)].
    Wolff A; Ionesco H
    Ann Microbiol (Paris); 1975; 126(3):343-56. PubMed ID: 174471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and some properties of the hemolytic toxin aerolysin.
    Buckley JT; Halasa LN; Lund KD; MacIntyre S
    Can J Biochem; 1981 Jun; 59(6):430-5. PubMed ID: 6794885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and characterization of Bordetella bronchiseptica dermonecrotic toxin.
    Horiguchi Y; Nakai T; Kume K
    Microb Pathog; 1989 May; 6(5):361-8. PubMed ID: 2770506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identity of hemolysins produced by Bacillus thuringiensis and Bacillus cereus.
    Honda T; Shiba A; Seo S; Yamamoto J; Matsuyama J; Miwatani T
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):205-9. PubMed ID: 1905656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and some properties of a Bacillus cereus mouse lethal toxin.
    Shinagawa K; Ichikawa K; Matsusaka N; Sugii S
    J Vet Med Sci; 1991 Jun; 53(3):469-74. PubMed ID: 1832034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and properties of Clostridium difficile cytotoxin B.
    Pothoulakis C; Barone LM; Ely R; Faris B; Clark ME; Franzblau C; LaMont JT
    J Biol Chem; 1986 Jan; 261(3):1316-21. PubMed ID: 3944088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and properties of beta-fructofuranosidase from Clostridium perfringens.
    Ishimoto M; Nakamura A
    Biosci Biotechnol Biochem; 1997 Apr; 61(4):599-603. PubMed ID: 9145517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of one tryptophan residue in the lethal activity of Clostridium perfringens epsilon toxin.
    Sakurai J; Nagahama M
    Biochem Biophys Res Commun; 1985 Apr; 128(2):760-6. PubMed ID: 2859854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium difficile toxin B: characterization and sequence of three peptides.
    Bisseret F; Keith G; Rihn B; Amiri I; Werneburg B; Girardot R; Baldacini O; Green G; Nguyen VK; Monteil H
    J Chromatogr; 1989 May; 490(1):91-100. PubMed ID: 2474559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Alpha and theta toxin Clostridium perfringens infection complicated by septic shock and hemolysis].
    Pastene B; Grégoire E; Blasco V; Albanèse J
    Ann Fr Anesth Reanim; 2014; 33(9-10):552-3. PubMed ID: 25154792
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.